ReviewBlood advances2018
Evaluating measurable residual disease in acute myeloid leukemia.
Farhad Ravandi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
76 papers cite itlatest 60 shown
this papertrialcites it
ReviewBlood advances2018
Farhad Ravandi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.